Ina Sarel
Keine laufenden Positionen mehr
Profil
Ina Sarel worked as a Director of Research & Development at TheraVitae, Inc., a Project Manager at Proneuron Biotechnologies, Inc., and a Vice President of Research & Development at Hemostemix, Inc. She holds a doctorate degree from Boston University and a graduate degree from The Hebrew University of Jerusalem.
Ehemalige bekannte Positionen von Ina Sarel
Unternehmen | Position | Ende |
---|---|---|
HEMOSTEMIX INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ina Sarel
The Hebrew University of Jerusalem | Graduate Degree |
Boston University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HEMOSTEMIX INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |